Rights and permissions
About this article
Cite this article
Interferon-α-2b + ribavirin: genotype-based therapy cost effective in chronic hepatitis C. Pharmacoecon. Outcomes News 244, 6 (2000). https://doi.org/10.1007/BF03266763
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03266763